CASR and ovarian carcinoma: In addition, exosomal miR-429 was demonstrated to enhance the proliferation and drug resistance of ovarian cancer cells by targeting the calcium-sensing receptor (CASR)/STAT3 pathway, which indicates that miR-429 may act as a primary regulator of chemoresistance [42].